Vermillion Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,566.00
2,521.00
2,177.00
2,642.00
3,121.00
3,053
Cost of Goods Sold (COGS) incl. D&A
170.00
1,230.00
2,309.00
2,698.00
2,914.00
3,142
Gross Income
2,396.00
1,291.00
132.00
56.00
207.00
89
SG&A Expense
11,259.00
20,304.00
19,117.00
14,898.00
10,648.00
11,244
EBIT
8,863.00
19,013.00
19,249.00
14,954.00
10,441.00
11,333
Unusual Expense
-
198.00
37.00
-
-
-
Non Operating Income/Expense
21.00
38.00
69.00
14.00
14.00
16
Interest Expense
-
-
-
28.00
42.00
22
Pretax Income
8,819.00
19,209.00
19,115.00
14,968.00
10,497.00
11,371
Consolidated Net Income
8,819.00
19,209.00
19,115.00
14,968.00
10,497.00
11,371
Net Income
8,819.00
19,209.00
19,115.00
14,968.00
10,497.00
11,371
Net Income After Extraordinaries
8,819.00
19,209.00
19,115.00
14,968.00
10,497.00
11,371
Net Income Available to Common
8,819.00
19,209.00
19,115.00
14,968.00
11,439.00
11,371
EPS (Basic)
0.42
0.53
0.41
0.29
0.20
0.16
Basic Shares Outstanding
20,926.30
36,082.40
47,124.30
52,198.00
56,943.60
70,085.80
EPS (Diluted)
0.42
0.53
0.41
0.29
0.20
0.16
Diluted Shares Outstanding
20,926.30
36,082.40
47,124.30
52,198.00
56,943.60
70,085.80
EBITDA
8,791.00
18,872.00
18,958.00
14,231.00
9,655.00
10,658
Non-Operating Interest Income
23.00
40.00
28.00
-
-
-
Preferred Dividends
-
-
-
-
942.00
-

About Vermillion

View Profile
Address
12117 Bee Caves Road
Austin Texas 78738
United States
Employees -
Website http://www.vermillion.com
Updated 07/08/2019
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women.